Single base substitution and insertion/deletion mutational signatures in adult core binding factor acute myeloid leukemia
Open Access
- 1 April 2022
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 36 (6) , 1681-1684
Abstract
No abstract availableKeywords
Funding Information
- Barncancerfonden (TJ2020-0024, PR2020-0033)
- Cancerfonden (20 0792 PjF)
- Vetenskapsrådet (2020-01164)
This publication has 11 references indexed in Scilit:
- Comprehensive analysis of mutational signatures in pediatric cancersbioRxiv, 2021
- Mutation Signatures of Pediatric Acute Myeloid Leukemia and Normal Blood Progenitors Associated with Differential Patient OutcomesBlood Cancer Discovery, 2021
- Single base substitution mutational signatures in pediatric acute myeloid leukemia based on whole genome sequencingLeukemia, 2021
- Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implicationBlood Advances, 2020
- Single-cell whole-genome sequencing reveals the functional landscape of somatic mutations in B lymphocytes across the human lifespanProceedings of the National Academy of Sciences, 2019
- Whole genome sequencing analysis for cancer genomics and precision medicineCancer Science, 2018
- The genomic landscape of core-binding factor acute myeloid leukemiasNature Genetics, 2016
- The leukemia-associated RUNX1/ETO oncoprotein confers a mutator phenotypeLeukemia, 2015
- Signatures of mutational processes in human cancerNature, 2013
- Molecular and Clinical Advances in Core Binding Factor Primary Acute Myeloid Leukemia: A Paradigm for Translational Research in Malignant HematologyCancer Investigation, 2000